Aurora BayCare Medical Center Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2015
NCT02300727
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Aurora BayCare Medical Center | Dhimant Patel

Active Ingredients

Drugs in Phase 2 Trials (1)

curcumin (1 trial)

Drugs in Other Trials (2)

sweet marjoram essential oil (1 trial)

vitis vinifera (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Mucositis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 3